Outlook Therapeutics
OTLK
OTLK
87 hedge funds and large institutions have $12M invested in Outlook Therapeutics in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 12 closing their positions.
Holders
87
Holders Change
+6
Holders Change %
+7.41%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$4.08M |
2 |
2
Morgan Stanley
New York
|
$398K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$2.58M |
4 |
4
Millennium Management
New York
|
$109K |
5 |
5
Barclays
London,
United Kingdom
|
$85K |